Caribou Biosciences Inc (CRBU)
3.395
-0.20
(-5.43%)
USD |
NASDAQ |
May 17, 16:00
3.395
0.00 (0.00%)
After-Hours: 20:00
Caribou Biosciences Profit Margin (Quarterly): -1.70K% for March 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -1.70K% |
| December 31, 2023 | -969.8% |
| September 30, 2023 | -42.27% |
| June 30, 2023 | -786.1% |
| March 31, 2023 | -800.8% |
| December 31, 2022 | -731.0% |
| September 30, 2022 | -806.8% |
| June 30, 2022 | -636.9% |
| March 31, 2022 | -716.5% |
| Date | Value |
|---|---|
| December 31, 2021 | -722.1% |
| September 30, 2021 | -527.4% |
| June 30, 2021 | -969.6% |
| March 31, 2021 | -829.7% |
| December 31, 2020 | -1.49K% |
| September 30, 2020 | -662.2% |
| June 30, 2020 | -22.08% |
| March 31, 2020 | -576.1% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-1.70K%
Minimum
Mar 2024
-22.08%
Maximum
Jun 2020
-764.2%
Average
-731.0%
Median
Dec 2022
Profit Margin (Quarterly) Benchmarks
| Regeneron Pharmaceuticals Inc | 22.96% |
| Sangamo Therapeutics Inc | -10.21K% |
| Vertex Pharmaceuticals Inc | 40.87% |
| Regulus Therapeutics Inc | -- |
| Anavex Life Sciences Corp | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -34.77% |
| Return on Assets | -28.91% |
| Return on Invested Capital | -34.77% |
| Operating Margin (Quarterly) | -1.89K% |
| Return on Net Operating Assets | -239.0% |